Man Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Man Group’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-270,198	Closed	-$12.7M	–	2012
2019 Q4	$12.7M	Buy	+270,198	New	+$11.9M	0.04%	564
2019 Q2	–	Sell	-70,657	Closed	-$1.58M	–	2089
2019 Q1	$1.58M	Sell	70,657 -136,824	-66%	-$2.94M	0.01%	1428
2018 Q4	$3.78M	Buy	+207,481	New	+$3.26M	0.02%	912

Other funds holding RARX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Man Group's RARX Position: Q1 2020 in Review

Man Group sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q1 2020, closing a stake of 270,198 shares — an estimated $12.7M sold.

Man Group first reported a position in RARX in Q4 2018 and held it in 3 quarters. The position peaked at $12.7M in Q4 2019. 144 funds tracked by Wall St. Rank hold RARX as of Q1 2020.

Man Group reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Man Group sold 270,198 Ra Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $12.7M.
Man Group first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
Man Group's Ra Pharmaceuticals, Inc. Common Stock position peaked at $12.7M in Q4 2019.
144 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Man Group's 13F filing for Q1 2020, filed 15 May 2020.